Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

G Boriani, CT Ruff, JF Kuder, M Shi… - European heart …, 2019 - academic.oup.com
Aims To investigate the relationship between body mass index (BMI) and outcomes in
patients with atrial fibrillation (AF). Methods and results In the ENGAGE AF-TIMI 48 trial …

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.

G Boriani, CT Ruff, JF Kuder, M Shi, HJ Lanz… - European Heart …, 2019 - europepmc.org
Aims To investigate the relationship between body mass index (BMI) and outcomes in
patients with atrial fibrillation (AF). Methods and results In the ENGAGE AF-TIMI 48 trial …

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.

G Boriani, CT Ruff, JF Kuder, M Shi… - European Heart …, 2019 - search.ebscohost.com
Aims To investigate the relationship between body mass index (BMI) and outcomes in
patients with atrial fibrillation (AF). Methods and results In the ENGAGE AF-TIMI 48 trial …

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

G Boriani, CT Ruff, JF Kuder, M Shi… - European Heart …, 2019 - academic.oup.com
Aims To investigate the relationship between body mass index (BMI) and outcomes in
patients with atrial fibrillation (AF). Methods and results In the ENGAGE AF-TIMI 48 trial …

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

G Boriani, CT Ruff, JF Kuder, M Shi, HJ Lanz… - 2019 - pubmed.ncbi.nlm.nih.gov
Aims To investigate the relationship between body mass index (BMI) and outcomes in
patients with atrial fibrillation (AF). Methods and results In the ENGAGE AF-TIMI 48 trial …

[PDF][PDF] Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

G Boriani, CT Ruff, JF Kuder, M Shi, HJ Lanz… - European Heart …, 2019 - core.ac.uk
OP-EHEA180883_online 1541..1550 Page 1 ............... Relationship between body mass index
and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the …

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.

G Boriani, CT Ruff, JF Kuder, SMG Shi MingGao… - 2019 - cabidigitallibrary.org
Aims: To investigate the relationship between body mass index (BMI) and outcomes in
patients with atrial fibrillation (AF). Methods and results: In the ENGAGE AF-TIMI 48 trial …

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

G Boriani, CT Ruff, JF Kuder, M Shi, HJ Lanz… - EUROPEAN HEART …, 2019 - iris.unimore.it
Aims To investigate the relationship between body mass index (BMI) and outcomes in
patients with atrial fibrillation (AF). Methods and results In the ENGAGE AF-TIMI 48 trial …

[PDF][PDF] Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

G Boriani, CT Ruff, JF Kuder, M Shi, HJ Lanz… - European Heart …, 2019 - iris.unimore.it
OP-EHEA180883_online 1541..1550 Page 1 ............... Relationship between body mass index
and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the …